A Global Perspective on Vaccine Safety and Public Health: The Global Advisory Committee on Vaccine Safety

A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety.

Established in 1999, the Global Advisory Committee on Vaccine Safety advises the World Health Organization (WHO) on vaccine-related safety issues and enables WHO to respond promptly, efficiently, and with scientific rigor to issues of vaccine safety with potential global importance. The committee also assesses the implications of vaccine safety for practice worldwide and for WHO policies. We de...

Global Advisory Committee on Vaccine Safety, June 2012.

Global Advisory Committee on Vaccine Safety, 12-13 December 2007.

10:30-10:45 Overview of reported events and investigations A. Bentsi-Enchill 10:45-11:00 Update on virological and clinical investigation A. Barrett 11:00-11:15 Discussion 11:15-12:00 Hepatitis B vaccination and arthritis: update and finalization of statement Purpose of the session: Updating of current GACVS statement on hepatitis B vaccination and rheumatoid arthritis and publication of statem...

Global Advisory Committee on Vaccine Safety review of pentavalent vaccine safety concerns in four Asian countries

Since 2008, Haemophilus influenza type b (Hib) vaccine has increasingly been introduced into Asian countries immunisation programmes. Hib vaccine has mainly been introduced as a combination pentavalent vaccine, which has replaced the traditional DTwP or DTPwP-HepB vaccines. As expected with the introduction of a new vaccine, there has been increased attention to serious adverse events following...

Capacity for a global vaccine safety system: the perspective of national regulatory authorities.

Confidence in vaccine safety is critical to national immunization strategies and to global public health. To meet the Millenium Development Goals, and buoyed by the success of new vaccines produced in developing countries, the World Health Organization has been developing a strategy to establish a global system for effective vaccine pharmacovigilance in all countries. This paper reports the fin...